Disseminated lung opacities and cavitation associated with Strongyloides stercoralis and Schistosoma mansoni infection.
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D004802:Eosinophilia; D005002:Ethiopia; D005334:Fever; D005387:Finland; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000150:complications*; D007538:Isoniazid / Q000627:therapeutic use; D008174:Lung Diseases, Parasitic / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008297:Male; D009560:Niridazole / Q000009:adverse effects / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced; D011859:Radiography; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000150:complications* / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013322:Strongyloidiasis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D013827:Thiabendazole / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy; D014398:Tuberculosis, Renal / Q000150:complications / Q000188:drug therapy / Q000209:etiology
D000636:Aminosalicylic Acids; D010406:Penicillins; D009560:Niridazole; D013827:Thiabendazole; D007538:Isoniazid; D013307:Streptomycin